Viewing Study NCT01068392


Ignite Creation Date: 2025-12-24 @ 3:20 PM
Ignite Modification Date: 2025-12-26 @ 12:50 PM
Study NCT ID: NCT01068392
Status: COMPLETED
Last Update Posted: 2014-11-04
First Post: 2010-02-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Oxaliplatin and Prednisolone (Ox-P) for Patients With Relapsed or Refractory Marginal Zone B-cell Lymphoma(MZL)
Sponsor: Dong-A University Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module